/
Immunology
327Diseases↗
4.6KPipeline Programs↗
1.6KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
8,024
clinical trials
Completed4,821 · 60%
Recruiting848 · 11%
Terminated730 · 9%
Unknown status614 · 8%
Active, not recruiting337 · 4%
Not yet recruiting333 · 4%
Other341 · 4%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
Landscape
Diseases
Systemic Lupus Erythematosus
Most programs270
Programs
664
Trials
81
Recruiting
Pre
34
P1
112
P2
108
P3
45
Appr
30
Most programs:
Roche
RocheRheumatoid Arthritis
Most trials672
Programs
119
Trials
70
Recruiting
Pre
110
P1
120
P2
292
P3
157
Appr
113
Most programs:
Pfizer
PfizerPsoriasis
Highest activity450
Programs
154
Trials
56
Recruiting
Pre
66
P1
98
P2
229
P3
128
Appr
85
Most programs:
LEO Pharma
LEO PharmaUlcerative Colitis
9381 programs166 trialsApproved
Atopic Dermatitis
9373 programs169 trialsApproved
Immunodeficiency
5232 programs41 trialsApproved
Allergic Rhinitis
194 programs46 trialsApproved
Lupus
116 programs199 trialsApproved
Crohn's Disease
871 programs130 trialsApproved
Systemic Sclerosis
2135 programs46 trialsApproved
Psoriatic Arthritis
101 programs55 trialsApproved
Myasthenia Gravis
384 programs71 trialsApproved
Lupus Erythematosus
9 programs142 trialsApproved
Allergy
108 programs29 trialsApproved
Graft Versus Host Disease
388 programs33 trialsApproved
Oral Mucositis
98 programs21 trialsApproved
Alopecia Areata
484 programs35 trialsApproved
Seasonal Allergic Rhinitis
195 programs13 trialsApproved
HAE
0 programs94 trials
Mucositis
154 programs23 trialsApproved
Vasculitis
147 programs28 trialsApproved
Rheumatic Disease
151 programs20 trialsApproved
Chronic Graft Versus Host Disease
251 programs10 trialsApproved
Allergic Conjunctivitis
57 programs2 trialsApproved
Allergic Asthma
153 programs6 trialsApproved
Scleroderma
147 programs11 trialsApproved
Acute Graft Versus Host Disease
145 programs7 trialsPhase 3
Refractory Autoimmune Diseases
0 programs49 trials
Angioedema
26 programs21 trialsApproved
Chronic Granulomatous Disease
235 programs11 trialsApproved
Showing top 30 diseases by activity. 297 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)